文献速递帕金森病与运动障碍认知障碍与痴呆神经免疫

人类白细胞抗原等位基因与路易体病神经病理结局的关联

Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease.
PubMed 文献 · Ann Neurol · 2025-11-07

该研究纳入梅奥诊所脑库539例欧洲裔路易体病(LBD)病例,用全基因组测序高分辨率分型HLA等位基因,分析其与神经病理结局的关联。发现HLA-DPB1*06:01与海马旁回路易体计数较低显著相关,另有一些提示性关联,提示HLA介导的免疫机制可能参与LBD进展与亚型分化。

要点

  • HLA-DPB1*06:01与海马旁回路易体计数较低显著相关(P=3.30×10^-5)。
  • HLA-DRB1*11:01提示与较低Thal淀粉样蛋白分期相关(P=1.56×10^-4)。
  • HLA-B*15:01提示与弥漫性LBD风险增加相关(P=7.58×10^-4)。

核心结论

  • HLA等位基因变异与路易体病神经病理负担相关,支持免疫相关遗传因素在LBD病因中的作用。

研究设计与样本

  • 研究纳入梅奥诊所脑库539例欧洲裔神经病理确诊的LBD病例,采用高分辨率全基因组测序并用HLA*LA工具进行HLA等位基因分型。

主要发现

  • 分析发现1个显著关联(P<3.43×10^-5)和4个提示性关联(P<0.001)涉及HLA等位基因与特定神经病理结局。
  • HLA-DPB1*06:01与海马旁回路易体计数较低显著相关(P=3.30×10^-5),在中额回(P=1.80×10^-4)和下顶回(P=6.33×10^-4)呈较弱提示性关联。
  • HLA-DRB1*11:01提示与较低Thal淀粉样蛋白分期相关(P=1.56×10^-4)。
  • HLA-B*15:01提示与弥漫性LBD风险增加相关(P=7.58×10^-4)。

关键数值与推荐

  • 显著关联阈值定为P<3.43×10^-5,提示性关联阈值定为P<0.001。

临床怎么用

  • 结果提示HLA分型可能有助于理解LBD病理负担和亚型差异,但目前尚不能作为临床常规检测或分型依据。

局限性

  • 研究仅纳入欧洲裔人群,部分关联仅为提示性,需独立队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lewy body disease (LBD) is a complex neurodegenerative disorder characterized by the accumulation of misfolded α-synuclein in the brain. Neuroinflammation has long been implicated in LBD pathogenesis, and recent genetic studies in Parkinson's disease (a clinical manifestation of LBD) have shown consistent association with the human leukocyte antigen (HLA) gene complex. Here, we assessed whether variation in HLA alleles influences neuropathological burden in a neuropathologically-defined series of LBD cases. METHODS: We conducted a comprehensive analysis of HLA allelic variants in a cohort of 539 LBD cases of European descent from the Mayo Clinic brain bank. High-resolution whole-genome sequencing was used, and the HLA alleles of each sample were called using the HLA*LA tool and assessed for association with neuropathological outcomes. RESULTS: Our analysis identified 1 significant (P < 3.43 × 10-5) and 4 suggestive (P < 0.001) associations between certain HLA alleles and specific neuropathological outcomes in LBD, suggesting a potential role for HLA-mediated immune mechanisms in disease progression and subtype differentiation. Specifically, HLA-DPB1*06:01 was significantly associated with lower Lewy body counts in the parahippocampal gyrus (P = 3.30 × 10-5), with weaker and suggestive associations observed in the middle frontal (P = 1.80 × 10-4) and inferior parietal gyrus (P = 6.33 × 10-4). Additionally, although only suggestive, HLA-DRB1*11:01 correlated with a lower Thal amyloid phase (P = 1.56 x 10-4), and HLA-B*15:01 correlated with an increased risk of diffuse LBD (P = 7.58 x 10-4). INTERPRETATION: This study provides a detailed evaluation of the relationship between HLA alleles and LBD pathology, highlighting the importance of immune-related genetic factors in the etiology of LBD. ANN NEUROL 2026;99:492-501.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Gavrielatos M, Heckman MG, Soto-Beasley AI, et al. Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease. Ann Neurol. 2025. PMID: 41200866. doi:10.1002/ana.78075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。